Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis

Pediatric Diabetes

Volumn 14, Issue 5, 2013, Pages 333-340

  Redondo, Maria J ^a   Rodriguez, Luisa M ^a   Escalante, Mirna ^a   Smith, E O'Brian ^a   Balasubramanyam, Ashok ^a   Haymond, Morey W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Autoantibodies; C peptide; Children; Classification; Diabetes

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; C PEPTIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; HEMOGLOBIN A1C; INSULIN; ISLET CELL AUTOANTIGEN 512; STEROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; BODY MASS; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PUBERTY; RACE;

EID: 84881027402     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12022     Document Type: Article

References (22)

1. SEARCH for Diabetes in Youth Study Group. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for diabetes in youth study. Pediatrics 2006: 118: 1510-1518.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012: 35 (Suppl. 1): S64-71.
3. Hanas R, Donaghue KC, Klingensmith G, Swift PG. ISPAD clinical practice consensus guidelines 2009 compendium (Introduction). Pediatr Diabetes 2009: 10 (Suppl. 12): 1-2.
4. Dabelea D, Pihoker C, Talton JW et al. SEARCH for Diabetes in Youth Study. Etiological approach to characterization of diabetes type: the SEARCH for diabetes. Diabetes Care 2011: 34: 1628-1633.
5. Balasubramanyam A, Garza G, Rodriguez L et al. Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care 2006: 29: 2575-9.
6. Maldonado M, Hampe CS, Gaur LK et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 2003: 88: 5090-8.
7. Ludvigsson J, Carlsson A, Forsander G et al. C-peptide in the classification of diabetes in children and adolescents. Pediatr Diabetes 2012: 13: 45-50.
8. Redondo MJ, Rodriguez LM, Escalante M, O'Brian Smith E, Balasubramanyam A, Haymond MW. Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes 2012: 13: 564-71.
9. Keenan HA, Sun JK, Levine J et al. Diabetes. Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010: 59: 2846-53.
10. Palmer JP, Fleming GA, Greenbaum CJ et al. C-peptide is the appropriate outcome measure for T1Dclinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004: 53: 250-64.
11. The DCCT Research Group. Effect of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987: 65: 30-6.
12. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med 1998: 128: 517-23.
13. Ogden CL, Flegal KM. Changes in terminology for childhood overweight and obesity. Natl Health Stat Rep 2010: 25: 1-8.
14. Wilking TJ. The accelerator hypothesis: weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia 2001: 44: 914-922.
15. Wenzlau JM, Juhl K, Yu L et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007: 104: 17040-5.
16. Nakhla M, Polychronakos C. Monogenic and other unusual causes of diabetes mellitus. Pediatr Clin N Am 2005: 52: 1637-1650.
17. Nalini R, Gaur LK, Maldonado M et al. HLA class II alleles specify phenotypes of ketosis-prone diabetes. Diabetes Care 2008: 31: 1195-200.
18. Wahren J, Kallas A, Sima AA. The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes 2012: 61: 761-72.
19. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004: 47: 1661-1667.
20. Dabelea D, D'Agostino RB, Mason CC et al. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth Study. Diabetologia 2011: 54: 78-86.
21. American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care 2012: 35 (Suppl. 1): S11-35.
22. Barker LE, Kirtland KA, Gregg EW, Geiss LS, Thompson TJ. Geographic distribution of diagnosed diabetes in the U.S. A diabetes belt. Am J Prev Med 2011: 40: 434-439.